ELMD
Get informed when a big investor buys or sells
+ FollowUndervalued by 106.2% based on the discounted cash flow analysis.
| Market cap | $337.25 Million |
|---|---|
| Enterprise Value | $320.26 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.9 |
| Beta | 0.5 |
| Outstanding Shares | 8,211,220 |
| P/E Ratio | 33.39 |
|---|---|
| PEG | 56.77 |
| Price to Sales | 5.27 |
| Price to Book Ratio | 8.43 |
| Enterprise Value to Revenue | 4.46 |
| Enterprise Value to EBIT | 24.21 |
| Enterprise Value to Net Income | 31 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 9.56%▼ 44.00% |
|---|---|
| Total Invested | $33.22M▼ 67.98% |
| Investors Holding | 26▼ 77.00% |
No data
Electromed manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest® Airway Clearance System, to patients with compromised pulmonary function. The Company is headquartered in New Prague, Minnesota and was founded in 1992.